Clinical trials
Phase 1/2 Primary Immunodeficiency Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bellicum Pharmaceuticals | 3 |
| Diane George | 2 |
| Genethon | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| ASIS Corporation | 1 |
| Baxalta now part of Shire | 1 |
| Baylor College of Medicine | 1 |
| Children's Hospital of Fudan University | 1 |
| Karolinska University Hospital | 1 |
| New York Medical College | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Immunodeficiency Diseases | 16 |
| Anemia, Aplastic | 5 |
| Anemia, Diamond-Blackfan | 4 |
| Anemia, Sickle Cell | 4 |
| Hemoglobinopathies | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Myelodysplastic Syndromes | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Cytopenia | 3 |
| Hematologic Neoplasms | 3 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.